Efficacy of Intravenous Oxytocin to Speed Recovery After THA

Enrolling by invitation · Phase 2 · Has a placebo group

Conditions studied: Total Hip Arthroplasty

In brief

The purpose of this study is to test whether perioperative intravenous (IV) oxytocin compared to placebo results in faster recovery in disability as measured by daily steps over 56 days after Total Hip Arthroplasty (THA).

Key facts

Study ID
NCT07430228
Run by
Wake Forest University Health Sciences
People needed
80
Starts
2026-08-01
Expected to finish
2027-12-01
Last updated by the study team
2026-07-28

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.